| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/27/2008 | US20080075741 Recombinant P. falciparum merozoite protein-1 42 vaccine |
| 03/27/2008 | US20080075740 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 03/27/2008 | US20080075739 Attenuated Salmonella SP12 Mutants as Antigen Carriers |
| 03/27/2008 | US20080075738 synthetic polypeptide biodrugs for treating viral disease; envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 03/27/2008 | US20080075737 inducing an immune response to an HIV antigen; genetic engineered polypeptide; inserted into cell; improves or restores the blood clotting time, blood disorders; gene therapy |
| 03/27/2008 | US20080075735 Demethylated and/or oxidized membrane DNA |
| 03/27/2008 | US20080075733 receptor for advanced glycosylation end products polypeptide directly linked to a polypeptide comprising a CH2 domain of an immunoglobulin; biodrug for treating amyloidosis, Alzheimer's disease, cancer, autoimmune disease, inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis |
| 03/27/2008 | US20080075725 Novel Immunointeractive Molecules and uses Thereof |
| 03/27/2008 | US20080075724 Nucleotide sequeces coding protein for use in the detection, diagnosis and treatment cell proliferative, autoimmune diseases, inflammation and infection; biodrugs as antiinflammatory agents, antiproliferative agents |
| 03/27/2008 | US20080075722 detecting the presence of a protein marker in patient sample, using a reagent which specifically binds with protein; comparing the copy number of a minimal common region; anticarcinogenic biodrugs |
| 03/27/2008 | US20080075721 Method of treating fibrosis |
| 03/27/2008 | US20080075717 Antigen Imitating Extracellular Areas of Membrane Proteins of Type III Produced from Intracellular Pathogenic Micro-Organisms, Derived Conformational Antibodies and the Use Thereof |
| 03/27/2008 | US20080075716 purified and/or genetic engineered antibodies or fragments comprises variable heavy or light chain peptides capable of binding oxidized fragments of alipoproteins, used as vaccines against cardiovascular disorders |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |
| 03/27/2008 | US20080075693 Methods for treating viral infection using il-28 and il-29 cysteine mutants |
| 03/27/2008 | US20080075690 tumor necrosis factor alpha (TNF alpha ) mutein attached to substrates, to create an adsorbent matrix, that permit binding of immune system inhibitors such as soluble TNF receptors, thereby inducing a vigorous immune response while minimizing toxicity |
| 03/27/2008 | US20080075684 peptide sequences having a high receptivity for keratin or keratin-containing materials such as skin or hair, suitable for the cosmetic and pharmaceutical treatment of hair and skin |
| 03/27/2008 | US20080075672 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 03/27/2008 | DE102006043891A1 Serumfreies Medium zur Differenzierung von Stammzellen Serum-free medium for the differentiation of stem cells |
| 03/27/2008 | CA2665816A1 Antigen specific multi epitope vaccines |
| 03/27/2008 | CA2664423A1 Modulating regulatory t cell activity via interleukin 35 |
| 03/27/2008 | CA2663722A1 Collagen preparation and method of isolation |
| 03/27/2008 | CA2663545A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof |
| 03/27/2008 | CA2663074A1 Protease resistant insulin analogues |
| 03/27/2008 | CA2660795A1 Optimized antibodies that target hm1.24 |
| 03/27/2008 | CA2654718A1 Methods of identifying insect-specific spider toxin mimics |
| 03/27/2008 | CA2654438A1 Crystal structure of crig and c3b:crig complex |
| 03/27/2008 | CA2644273A1 Process for the production of a fine chemical |
| 03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 03/26/2008 | EP1903112A2 Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family |
| 03/26/2008 | EP1903111A2 Extended cDNAs for secreted proteins |
| 03/26/2008 | EP1903058A2 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1903056A2 HLA-A1, -A2 -A3, -A24, -B7, and -B44 tumor associated antigen peptides and compositions |
| 03/26/2008 | EP1903055A2 Recombinant haemophilus influenzae adhesin proteins |
| 03/26/2008 | EP1903054A2 Pharmaceutical compound containing a stabilised mRNA which is optimised for translation in its coded areas |
| 03/26/2008 | EP1902068A1 Egfr inhibitors promote axon regeneration |
| 03/26/2008 | EP1902067A2 Alleles of the opca gene from coryneform bacteria |
| 03/26/2008 | EP1902066A2 Il-6 binding proteins |
| 03/26/2008 | EP1901777A2 Low-toxicity, long-circulating chimeras of human interferon-alpha analogs and interferon tau |
| 03/26/2008 | EP1901774A2 Multivalent entrain-and-amplify immunotherapeutics for carcinoma |
| 03/26/2008 | EP1901770A2 Methods for treatment of growth disorders |
| 03/26/2008 | EP1901768A1 Methods of modulating il-23 activity; related reagents |
| 03/26/2008 | EP1901765A1 Intralesional treatment of psoriasis |
| 03/26/2008 | EP1901761A2 Thrombospondin-1 derived peptides and treatment methods |
| 03/26/2008 | EP1723414A4 Npc1l1 (npc3) and methods of identifying ligands thereof |
| 03/26/2008 | EP1689886A4 Molecular marker associated with cmv resistance and use thereof |
| 03/26/2008 | EP1663294B1 Treatment of fibrotic disease |
| 03/26/2008 | EP1610811A4 Prevention and treatment of cardiac arrhythmias |
| 03/26/2008 | EP1604014A4 Gene expression in breast cancer |
| 03/26/2008 | EP1527089B1 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 03/26/2008 | EP1458880B1 Isolation tool for viable c-kit expressing cells |
| 03/26/2008 | EP1458866B1 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 03/26/2008 | EP1434789B1 Improved protein disaggregation and refolding using high pressure |
| 03/26/2008 | EP1189921A4 Synthetic genes for enhanced expression |
| 03/26/2008 | EP1179068B1 Interleukin-1 hy2 materials and methods |
| 03/26/2008 | EP1033953B1 Method of cross-linking keratin-based films, sheets, and bulk materials |
| 03/26/2008 | EP0917535B1 Neuroactive peptide |
| 03/26/2008 | EP0885242B1 Peptides and compounds that bind to a thrombopoietin receptor |
| 03/26/2008 | EP0879060B1 Vaccines against varicella zoster virus gene 63 product |
| 03/26/2008 | EP0871482B1 Recombinant vesiculoviruses and their uses |
| 03/26/2008 | EP0714405B1 Therapeutic and diagnostic agents for amyloidosis |
| 03/26/2008 | EP0672147B1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 03/26/2008 | CN101151372A Protein and its use in diagnosing alzheimer's disease |
| 03/26/2008 | CN101151363A Plant virus designated tomato torrado virus |
| 03/26/2008 | CN101151276A Method of producing protein by using hamster IGF-1 |
| 03/26/2008 | CN101151275A Methods for reducing the immunogenicity of cytokines and removal of cell surface markers |
| 03/26/2008 | CN101151274A ROR alpha for promoting the induction of Bmal1 expression |
| 03/26/2008 | CN101151272A Recombinant icosahedral virus like particle production in pseudomonads |
| 03/26/2008 | CN101151081A Use of proteins as demulsifying agents |
| 03/26/2008 | CN101151049A Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 03/26/2008 | CN101151043A Composition and methods for promoting wound healing and tissue regeneration |
| 03/26/2008 | CN101148678A Human papilloma virus vaccine and preparation method thereof |
| 03/26/2008 | CN101148675A Inhibin protein for inducing plant to resist disease and accelerate growth and gene sequence |
| 03/26/2008 | CN101148674A Clone and application of pleiotropy gene Ghd7 used for controlling rice grain production, ear sprouting period and plant height |
| 03/26/2008 | CN101148673A Soybean abloom time adjusting gene GAL1 |
| 03/26/2008 | CN101148672A Soybean abloom time adjusting gene GAL2 and application thereof |
| 03/26/2008 | CN101148671A Spartina anglica sodium hydrogen pump protein gene SaNHX and application thereof |
| 03/26/2008 | CN101148479A Recombination human collagen and biological synthesis method thereof |
| 03/26/2008 | CN101148473A Recombination human insulin and its coding gene and application |
| 03/26/2008 | CN101148472A Tumour inhibitory gene or protein and application thereof |
| 03/26/2008 | CN101148471A Buckwheat allergen, IgE kit thereof, preparation method and using method for the same |
| 03/26/2008 | CN101147807A Substances for preventing and treating autoimmune diseases |
| 03/26/2008 | CN100376676C Transport protein and coded gene for producing penicillium chrysogenum, and application |
| 03/26/2008 | CN100376598C Dog intravenous injection albumin, its preparing method and dog intravenous injection albumin preparation |
| 03/25/2008 | US7349834 Molecular motor |
| 03/25/2008 | US7349811 Designing primers which target and clone preferential gene sequences |
| 03/25/2008 | US7348468 Wuschel (wus) gene homologs |
| 03/25/2008 | US7348423 Nucleic acids encoding fusion peptides |
| 03/25/2008 | US7348422 Fused protein, gene therefor, recombinant vector, recombinant virus, and its use |
| 03/25/2008 | US7348421 Methods for production of p-hydroxybenzoate in bacteria |
| 03/25/2008 | US7348420 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 03/25/2008 | US7348418 Comprises nucleotide sequences coding oncogenic polypeptides for diagnosis, detection and treatment of cancer |
| 03/25/2008 | US7348414 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 03/25/2008 | US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins |
| 03/25/2008 | US7348409 Antimicrobially active peptide |
| 03/25/2008 | US7348408 Membrane protein fusion for use as diagnostic tool in genetic engineering; reporter gene expression |
| 03/25/2008 | US7348407 Stress-responsive activator of p300 (strap) protein |
| 03/25/2008 | US7348406 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/25/2008 | US7348405 PRO10274 polypeptides |